Trial Profile
The post-marketing clinical study of Influenza vaccine(split virion)
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 06 Jun 2016
Price :
$35
*
At a glance
- Drugs Influenza virus vaccine (Primary)
- Indications Influenza virus infections
- Focus Adverse reactions; Pharmacodynamics
- Sponsors Changchun Institute of Biological Products
- 28 Apr 2016 New trial record